Adverse effects of vaccine opacity

By Maitri Porecha in BFO #260, 09 Apr, 21

Spooky revelations made by the European Medicines Agency (EMA)—a body responsible for evaluating medical products—regarding the safety profile of AstraZeneca’s Covishield vaccine, hold deep lessons for India. Lesson on how India should go about investigating adverse events following immunisation (AEFI). The EMA investigated side-effects on a case-by-case basis and revealed the results to the public. So the world has now become conscious of rare side-effects of clotting—some of them even fatal—that are being linked to the Covishield jab.